Literature DB >> 6703386

Effects of halothane, enflurane, and isoflurane on hypoxic pulmonary vasoconstriction in rat lungs in vitro.

C Marshall, L Lindgren, B E Marshall.   

Abstract

Rat lungs were ventilated and perfused at a constant rate in vitro. The maximal hypoxic pulmonary vasoconstrictor (HPV) response was recorded by measuring the pulmonary artery pressure change when the inspired oxygen concentration was changed from 21% to 3% (with 5.5% carbon dioxide) in the absence of anesthetic vapor. In different experimental groups, the effects of halothane, enflurane, and isoflurane on HPV were examined. In random order the anesthetics were added to the inspired gas in concentrations of 0.25, 0.5, 1, 1.5, and 2 or 2.5 MAC units. The HPV pressor response to 3% oxygen in the presence of anesthetic agent was expressed as a per cent of the pressure response observed in the absence of anesthetic (R%MAX). All three agents depressed HPV in a dose-related manner. The concentrations in MAC units at which 50% depression of HPV (ED50) occurred was 0.47, 0.60, and 0.56 for halothane, isoflurane, and enflurane, respectively, and neither the ED50 values nor the slopes of these dose response curves were significantly different. It was concluded that these halogenated general anesthetics inhibit HPV with essentially the same potency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703386     DOI: 10.1097/00000542-198404000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  17 in total

1.  Arterial air embolism of venous origin in dogs: effect of nitrous oxide in combination with halothane and pentobarbitone.

Authors:  B D Butler; B C Leiman; J Katz
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

Review 2.  Pulmonary hypertension in children: perioperative management.

Authors:  F A Burrows; J R Klinck; M Rabinovitch; D J Bohn
Journal:  Can Anaesth Soc J       Date:  1986-09

3.  Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide.

Authors:  David M Baron; Binglan Yu; Chong Lei; Aranya Bagchi; Arkadi Beloiartsev; Christopher P Stowell; Andrea U Steinbicker; Rajeev Malhotra; Kenneth D Bloch; Warren M Zapol
Journal:  Anesthesiology       Date:  2012-03       Impact factor: 7.892

4.  Volatile anesthetics constrict pulmonary artery in rabbit lung perfusion model.

Authors:  Mitsuhiro Takemura; Yasuhiro Shiokawa; Shinji Okamoto; Hiroshi Uno; Koichi Futagawa; Yoshihisa Koga
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

5.  The use of neuromuscular blocking drugs in the intensive care unit: a US perspective.

Authors:  M J Murray; R A Strickland; C Weiler
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 6.  Clinical pharmacokinetics of the inhalational anaesthetics.

Authors:  O Dale; B R Brown
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

7.  Sevoflurane has no inhibitory effect on hypoxic pulmonary vasoconstriction (HPV) in dogs.

Authors:  T Okutomi; K Ikeda
Journal:  J Anesth       Date:  1990-04       Impact factor: 2.078

8.  Is hypoxic pulmonary vasoconstriction important during single lung ventilation in the lateral decubitus position?

Authors:  M Friedlander; A Sandler; B Kavanagh; T Winton; J Benumof
Journal:  Can J Anaesth       Date:  1994-01       Impact factor: 5.063

Review 9.  Adverse effects of general anaesthetics.

Authors:  M C Berthoud; C S Reilly
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 10.  Preparation of the intensive care patient for major surgery.

Authors:  B M Wolfe; P G Moore
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.